Novartis India Q3 net profit up 44 percent at Rs 18.74 crore
New Delhi: Novartis India reported a 43.82% increase in net profit at Rs18.74 crore for the third quarter ended December 2017.
The company had posted a net profit of Rs13.03 crore in the same period of the previous fiscal.
Total income of the company during the period under review stood at Rs170.55 crore compared with Rs179.46 crore in the same period of the last fiscal, Novartis India said in a BSE filing.
The board of directors of Novartis India also announced the appointment of Jawed Zia as vice chairman and managing director of the company effective 1 March 2018.
Jawed Zia is currently head of pharmaceuticals, Novartis India. Zia succeeds Ranjit Shahani who holds this position until 28 February 2018.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd